Author Archive: Abigail Hirsch

Abigail Hirsch

Abigail is the Director of Events Communications at BIO. Although she has lived in the Washington, DC, area for nearly eight years, she still considers Virginia Beach home, especially with her parents and closest friends still in the area. According to Abigail, there is nothing better than sitting on the beach with a good book and cold drink. In her spare time, she enjoys visiting antique stores, finishing her twin sister Brooke’s sentences and spending time with her two boys, Frank her English bulldog, and JP her soon-to-be husband. Check back often for updates, Abigail’s take on BIO related events, and much more. And please, be kind, this is her first venture in to the blogging world!

Latest Posts

Looking Ahead to the 2014 BIO Investor Forum, Biotech IPO Hopefuls Continue to Seek Funding

partnering1

As mentioned in Fierce Biotech, a new crop of biotech IPO hopefuls have recently thrown their hats into the ring. These three biotechs are targeting $175M in IPO cash, hoping to secure funding for oncology, pain, and rare diseases. In fact, there have been 96 IPOs since the passage of the JOBS Act in April of 2012. One important provision of the Act is the ability for emerging growth companies to conduct “testing the waters” meetings with Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

The 2014 BIO International Convention Closes in San Diego

Gaslamp

The 2014 BIO International Convention, where the global biotech community meets, connecting the people, companies and innovations that help to fulfill the promise of biotechnology through healing, fueling, and feeding the world, concluded  today at the San Diego Convention Center with a record number of partnering meetings. Hosted by the Biotechnology Industry Organization (BIO), the event drew 15,667 industry leaders, including nearly 2,500 CEO’s, from 50 states and 70 countries. Read more on BIO.org

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Big #BIO2014 News from San Diego

Scott-W-115x76jpg

Yesterday, BIO held a press conference at Janssen Labs in San Diego to share some exciting news about the 2014 BIO International Convention. First and foremost, BIO’s Scott Whittaker announced that former Secretary of State Hillary Rodham Clinton will deliver the Wednesday Keynote Address. Full details are available here. Scott was joined by Diego Miralles, Global Head, Innovation, for Janssen Pharmaceuticals as well as BIOCOM President Joe Panetta. Francis Barraza was present on behalf of San Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

BIO to Host Google+ Hangout with David Brancaccio

BIOORG-Campaign-GooglePlus

Join us for a preview discussion with David Brancaccio, host of American Public Media’s Marketplace Morning Report and Scientific American Worldview editors on March 25, 11AM-12PM, as we explore the main themes of this year’s Scorecard edition – The Cost & Benefits of Innovation. Editors will also discuss: Innovation’s true “value proposition” and the ways in which investing in science has multilayered societal returns; The biggest issues in biotech that continue to “flatten” the world and create common missions among countries; Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

#BIOCEO14: An Optimistic Outlook for 2014

Panel

The 16th Annual BIO CEO & Investor Conference​ concluded with a lively Closing Plenary Session examining the current capital market for IPOs, where the industry has been and where it’s headed in 2014. The panel unanimously agreed: 2013 was the year of the IPO. In total, 56 healthcare companies priced an IPO; 43 of these were biotech companies. Last year was the strongest IPO year since 2000 and the second strongest in history with over $10 Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,